Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 25, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy.

A O Naghavi1, D C Fernandez1, N Mesko2

  • 1Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Brachytherapy
|March 27, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Five-year outcomes of sparing level IB in node-positive, human papillomavirus-associated oropharyngeal carcinoma: A safety and efficacy analysis.

Oral oncology·2019
Same author

A novel entorhinal projection to the rat dentate gyrus: direct innervation of proximal dendrites and cell bodies of granule cells and GABAergic neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience·1996
Same author

Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.

Gastroenterology·1996
Same author

Effects of continuous low-dose-rate brachytherapy on the rectum of the rat.

Radiation research·1996
Same author

Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.

The American journal of tropical medicine and hygiene·1996

Updated guidelines recommend brachytherapy (BT) for soft tissue sarcoma (STS) management. Brachytherapy offers options for monotherapy in low-risk cases or as a boost to improve outcomes and reduce toxicity.

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Radiation therapy is a key treatment for soft tissue sarcomas (STS).
  • Brachytherapy (BT) is a significant radiation technique for STS with expanding applications.

Purpose of the Study:

  • To update clinicians on brachytherapy (BT) data for soft tissue sarcoma (STS).
  • To provide recommendations for utilizing BT in STS patient management.

Main Methods:

  • Developed by American Brachytherapy Society experts in STS and BT.
  • Based on a comprehensive literature review and clinical experience.

Main Results:

  • Guidelines address dose, fractionation, and technical aspects to enhance outcomes and minimize toxicity.
  • Brachytherapy can be used as monotherapy for low-risk STS or re-irradiation.
Keywords:
BrachytherapyRadiationRetroperitoneal sarcomaSoft tissue sarcoma

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Related Experiment Videos

Last Updated: Jul 25, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

  • Brachytherapy boost is recommended for high-risk cases or when BT alone is insufficient.
  • Delayed BT initiation (postoperative Day 5 or after wound closure) is advised to limit complications.

    • Conclusions:

    • Guidelines offer a review of evidence supporting BT in STS.
    • Provides indications and technique recommendations for optimal patient selection and outcomes.